Emerging Therapies in Myelofibrosis: Highlights From SOHO 2020
Lisa Nodzon, PhD, ARNP, AOCNP®
J Adv Pract Oncol 2021;12(suppl 1):16-17 |
© 2021 Harborside™
Lisa Nodzon, PhD, ARNP, AOCNP®, of Moffitt Cancer Center, highlights new therapies in development for myelofibrosis that were discussed by Srdan Verstovsek, MD, PhD, of The University of Texas MD Anderson Cancer Center, at the 2020 SOHO Annual Meeting.
For access to the full length article, please sign in